Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Farhad Kamali

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Current Opinion in Hematology|August 5, 2006
Genetic influences on the response to warfarinFarhad Kamali
Current Opinion in Investigational Drugs (London, England : 2000)|September 29, 2005
V-10153 (Vernalis)Farhad Kamali
Pain|August 26, 1998
Analgesic effects of lamotrigine and phenytoin on cold-induced pain: a crossover placebo-controlled study in healthy volunteersJames Webb, Farhad Kamali
Expert Opinion on Drug Metabolism & Toxicology|May 24, 2019
Pharmacogenetics of anticoagulants used for stroke prevention in patients with atrial fibrillationEmmanouela Kampouraki, Farhad Kamali
British Journal of Clinical Pharmacology|May 26, 2006
The future prospects of pharmacogenetics in oral anticoagulation therapyFarhad Kamali, Munir Pirmohamed
Annual Review of Medicine|August 19, 2009
Pharmacogenetics of warfarinFarhad Kamali, Hilary Wynne
Expert Review of Clinical Pharmacology|June 22, 2017
Dietary implications for patients receiving long-term oral anticoagulation therapy for treatment and prevention of thromboembolic diseaseEmmanouela Kampouraki, Farhad Kamali
European Journal of Haematology|October 18, 2006
Appraisal of current vitamin K dosing algorithms for the reversal of over-anticoagulation with warfarin: the need for a more tailored dosing regimenElizabeth A Sconce, Farhad Kamali
Annals of Hematology|August 22, 2008
Vitamin K deficiency amplifies anticoagulation response to ximelagatran: possible implications for direct thrombin inhibitors and their clinical safetyFarhad Kamali, Peter Wood, Alan Ward
Age and Ageing|March 12, 2015
The impact of genetics on the management of patients on warfarin awaiting surgerySalah Abohelaika, Hilary Wynne, Lance Cope, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Current Opinion in Hematology|August 5, 2006
Genetic influences on the response to warfarinFarhad Kamali
Current Opinion in Investigational Drugs (London, England : 2000)|September 29, 2005
V-10153 (Vernalis)Farhad Kamali
Pain|August 26, 1998
Analgesic effects of lamotrigine and phenytoin on cold-induced pain: a crossover placebo-controlled study in healthy volunteersJames Webb, Farhad Kamali
Expert Opinion on Drug Metabolism & Toxicology|May 24, 2019
Pharmacogenetics of anticoagulants used for stroke prevention in patients with atrial fibrillationEmmanouela Kampouraki, Farhad Kamali
British Journal of Clinical Pharmacology|May 26, 2006
The future prospects of pharmacogenetics in oral anticoagulation therapyFarhad Kamali, Munir Pirmohamed
Annual Review of Medicine|August 19, 2009
Pharmacogenetics of warfarinFarhad Kamali, Hilary Wynne
Expert Review of Clinical Pharmacology|June 22, 2017
Dietary implications for patients receiving long-term oral anticoagulation therapy for treatment and prevention of thromboembolic diseaseEmmanouela Kampouraki, Farhad Kamali
European Journal of Haematology|October 18, 2006
Appraisal of current vitamin K dosing algorithms for the reversal of over-anticoagulation with warfarin: the need for a more tailored dosing regimenElizabeth A Sconce, Farhad Kamali
Annals of Hematology|August 22, 2008
Vitamin K deficiency amplifies anticoagulation response to ximelagatran: possible implications for direct thrombin inhibitors and their clinical safetyFarhad Kamali, Peter Wood, Alan Ward
Age and Ageing|March 12, 2015
The impact of genetics on the management of patients on warfarin awaiting surgerySalah Abohelaika, Hilary Wynne, Lance Cope, et al.
Pageof 5